DK0457950T3 - Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme - Google Patents

Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme

Info

Publication number
DK0457950T3
DK0457950T3 DK90109883.0T DK90109883T DK0457950T3 DK 0457950 T3 DK0457950 T3 DK 0457950T3 DK 90109883 T DK90109883 T DK 90109883T DK 0457950 T3 DK0457950 T3 DK 0457950T3
Authority
DK
Denmark
Prior art keywords
treatment
inflammatory conditions
stearidonic acid
stearidonic
acid
Prior art date
Application number
DK90109883.0T
Other languages
English (en)
Inventor
Michel Guichardant
Michel Rigaud
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK0457950T3 publication Critical patent/DK0457950T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK90109883.0T 1990-05-23 1990-05-23 Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme DK0457950T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90109883A EP0457950B1 (fr) 1990-05-23 1990-05-23 Utilisation de l'acide stéaridonique pour le traitement des maladies inflammatoires

Publications (1)

Publication Number Publication Date
DK0457950T3 true DK0457950T3 (da) 1994-03-07

Family

ID=8204025

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90109883.0T DK0457950T3 (da) 1990-05-23 1990-05-23 Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme

Country Status (7)

Country Link
US (1) US5158975A (da)
EP (1) EP0457950B1 (da)
JP (1) JP3065710B2 (da)
DE (1) DE69004081T2 (da)
DK (1) DK0457950T3 (da)
ES (1) ES2059880T3 (da)
IE (1) IE65969B1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260465A (en) * 1991-12-16 1993-11-09 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
DE4432633C2 (de) * 1994-09-14 1997-07-31 Singer Peter Dr Med Priv Doz Pharmazeutisches Präparat zur lokalen Behandlung von Schuppenflechte, Neurodermitis und Ekzem
WO1997046220A1 (en) * 1996-06-03 1997-12-11 Croda International Plc Vegetable oil compositions
US6340485B1 (en) 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
JP4151853B2 (ja) * 1996-10-11 2008-09-17 スカリスタ リミテッド エイコサペンタエン酸および／またはステアリドン酸を含む治療用薬剤
US5855893A (en) * 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
DE10121252A1 (de) * 2001-04-30 2002-11-07 Christos C Zouboulis Behandlung der Akne
EP2275101A1 (en) * 2001-05-14 2011-01-19 Martek Biosciences Corporation Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses
BR0308290A (pt) * 2002-03-08 2005-01-11 Monsanto Technology Llc Tratamento e prevenção de distúrbios inflamatórios
AU2002951913A0 (en) * 2002-10-08 2002-10-24 Chevis Agriservices & Consulting Pty. Limited Method of treatment
WO2004112777A1 (ja) * 2003-06-20 2004-12-29 Mochida Pharmaceutical Co., Ltd. 下肢静脈瘤予防・治療用組成物
ATE430802T1 (de) 2003-08-21 2009-05-15 Monsanto Technology Llc Fettsäuredesaturasen aus primula
CN1968688A (zh) 2004-04-16 2007-05-23 孟山都技术有限公司 脂肪酸去饱和酶在玉米中的表达
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
EP1714564A1 (en) * 2005-04-21 2006-10-25 N.V. Nutricia Method for treatment and prevention of respiratory insufficiency
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0814105D0 (en) * 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
US8060617B2 (en) * 2008-12-19 2011-11-15 Cisco Technology, Inc. Reserving network resources during scheduling of meeting event
US8372465B2 (en) * 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
MA39718A (fr) * 2014-04-09 2017-02-15 Dignity Sciences Ltd Compositions et méthodes d'utilisation de celles-ci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
ATE22532T1 (de) * 1982-03-01 1986-10-15 Efamol Ltd Pharmazeutische zusammensetzung.
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
US4843095A (en) * 1987-08-07 1989-06-27 Century Laboratories, Inc. Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions

Also Published As

Publication number Publication date
DE69004081T2 (de) 1994-02-10
JPH04226915A (ja) 1992-08-17
IE65969B1 (en) 1995-11-29
ES2059880T3 (es) 1994-11-16
JP3065710B2 (ja) 2000-07-17
EP0457950A1 (fr) 1991-11-27
US5158975A (en) 1992-10-27
DE69004081D1 (de) 1993-11-25
IE911450A1 (en) 1991-12-04
EP0457950B1 (fr) 1993-10-20

Similar Documents

Publication Publication Date Title
DE69004081D1 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
DK176487A (da) Middel til behandling af inflammationer i oejet
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
FI912703A7 (fi) Oleellinen rasvahappokäsittely
FI920795A7 (fi) Kroonisten tulehdustilojen hoito
DK0679160T3 (da) Pyrimidinnucleotidpræcursorer til behandling af inflammatorisk hepatitis
DK439682A (da) Apparat til behandling af afgroede
DK0464381T3 (da) 2-Methoximinocarboxylsyreestere
FI922582A7 (fi) Rasvahappokäsittely
IT1121040B (it) Procedimento di depurazione delle acque residue
DK98684A (da) Fremgangsmaade til fremstilling af fedtsyreestere af ascorbinsyre
FI900688A0 (fi) Anordning foer luftning av liggunderlag i sjuksaeng.
TR25348A (tr) CISIMLERIN OTOMATIK SEKILDE YERLESTIRILMELERINI SAGLAYAN DüZEN
DK262982A (da) Fremgangsmaade til fremstilling af apovincaminsyreestere
DK0522212T3 (da) Anvendelsen af et middel til tyrosinaseinhibering
DK606184D0 (da) Fremgangsmaade til fremstilling af aconitsyre ved gaering og mikroorganisme til anvendelse derved
DK0519512T3 (da) Mikrobiologisk fremgangsmåde til fremstilling af 5-hydroxypyrazincarboxylsyre
DE59102569D1 (de) Sulfierte hydroxycarbonsäureester.
DK408782A (da) Fremgangsmaade til fremstilling af antranilsyreestere
FI910662A7 (fi) Menetelmä 7-amino-3-metoksimetyyli-kef-3-emi-4-karboksyylihapon valmistamiseksi
DK174591D0 (da) Fremgangsmaade til fremstilling af sorbinsyre
DK0569701T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-methyl-pyridin
FI920885L (fi) Paovisande av bakterier med bistaond av en nukleinsyraamplifikation
FI823287A0 (fi) Modifierad pao toluen-di-isocyanat varmed foerbaettrade poluuretanskum med mycket god slagseghet kanaostadkommas